Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama

By Eli Lilly and Company

Huntsville site will focus on domestic production of small molecule synthetic and peptide medicines, including Lilly's oral GLP-1 , orforglipron